Skip to main content
OpenTrials

Clinical trial condition

Borderline Resectable Pancreatic Adenocarcinoma

Explore clinical trials studying Borderline Resectable Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

17 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Borderline Resectable Pancreatic Adenocarcinoma trial results

Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06673017

Conditions
Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Northwell Health Zuckerberg Cancer Center Lake Success, New York, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

NCT06384560

Conditions
Borderline Resectable Pancreatic Adenocarcinoma, Localized Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Locations
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • Maastricht University Medical Center Maastricht, Netherlands
  • St. Antonius Ziekenhuis Nieuwegein, Netherlands
  • Erasmus University Medical Center Rotterdam, Netherlands
View Trial Details
Recruiting

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

NCT05083247

Conditions
Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Uza Antwerp Antwerp, Belgium
  • Hopital Erasme, HUB Brussels, Belgium
  • Jules Bordet Institute, HUB Brussels, Belgium
  • CHIREC Brussels, Belgium
View Trial Details

Related conditions